ArticleOncology research2026

UCK2 Drives Lung Adenocarcinoma Progression and Immune Dysregulation via the RHEB/mTOR Signaling Axis.

Xiaolin Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.